About Cytel
Cytel is a global clinical research organization that delivers advanced analytics, data science, and software solutions to pharmaceutical and biotechnology companies throughout the drug development lifecycle. The company specializes in innovative trial design methodologies including adaptive trial designs, Bayesian approaches, and model-informed drug development. Cytel's comprehensive service portfolio spans discovery and preclinical research, Phase I-III clinical trials, commercialization strategies, and real-world evidence generation. The organization offers strategic consulting, functional service provider models, and project-based analytical solutions tailored to client needs. Cytel's proprietary software platforms include East Horizon for trial design, the Xact software suite (including StatXact), Enforesys for trial implementation, and LiveSLR for systematic literature reviews. The company serves diverse therapeutic areas with particular expertise in rare diseases, oncology, and central nervous system disorders. Cytel provides specialized capabilities in health economics and outcomes research (HEOR), market access strategy, regulatory compliance, data monitoring committees, and real-world data analytics. Their solutions integrate advanced statistical methods with regulatory expertise to optimize trial efficiency, enhance probability of success, and accelerate time to market for new therapeutics.
Clinical Focus
Medical conditions and clinical areas addressed by Cytel.
Who It Serves
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.